Shari Esfahani

Orrick, Herrington & Sutcliffe LLP

Contact
View Bio
RSS

Latest Posts › Draft Guidance

Share:

FDA Proposes Draft Guidance on Assessing the Credibility of AI Models Used in Drug and Biological Product Submissions

The FDA has shared its first draft guidance on how sponsors should assess the credibility of artificial intelligence (AI) models to support FDA decisions regarding drug safety, effectiveness or quality. The agency noted an...more

1/17/2025  /  Artificial Intelligence , Draft Guidance , Food and Drug Administration (FDA) , Life Sciences , Machine Learning , Medical Devices , Pharmaceutical Industry , Risk Management
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide